Ultrasound Probe Reprocessing: Surface, Endocavity, and TEE Transducers

Ultrasound transducers are among the most frequently mishandled reusable devices in hospitals — and among the most expensive to replace. For hospital biomedical engineers and sterile processing staff managing imported or refurbished ultrasound systems, understanding the correct reprocessing pathway for each probe type is critical to protecting both patient safety and the significant capital investment represented by these devices. This article summarizes current guidance from the American Institute of Ultrasound in Medicine (AIUM), the CDC, and the FDA on cleaning and disinfecting surface, endocavity, and transesophageal echocardiography (TEE) probes, along with practical steps to prevent probe damage during reprocessing.

Classifying Probes Under the Spaulding System

Ultrasound transducers fall into different Spaulding categories depending on how they contact the patient:

The AIUM's official statement on transducer cleaning is unambiguous about cover reliability: because barrier sheaths and probe covers can fail, "the guidelines herein take into account possible transducer contamination due to a disruption in the barrier sheath," and internal transducers "require HLD before they can be used on another patient" regardless of cover use (AIUM, Guidelines for Cleaning and Preparing Ultrasound Transducers). This is consistent with CDC guidance stating that "a vaginal probe and all endocavitary probes without a probe cover are semicritical devices," and that HLD is still required because covers "can fail" (CDC, Disinfection of Healthcare Equipment).

Step-by-Step Reprocessing Workflow

1. Cleaning (All Transducers, Every Use)

• Disconnect the transducer from the scanner per the manufacturer's procedure.
• Remove the probe cover, if used, and discard it.
• Remove bulk gel and debris using a damp gauze pad or soft cloth with mild, nonabrasive liquid soap.
• Use a small brush for crevices or areas of angulation where gel or debris may accumulate, if appropriate for that probe's design (AIUM Guidelines).

2. Disinfection

• External/noncritical probes: low-level disinfection is sufficient for probes contacting only clean, intact skin. If contaminated with blood or body fluids, use a low-level disinfectant effective against bloodborne pathogens (HBV, HCV, HIV) (AIUM Guidelines).
• Endocavity and TEE probes: high-level disinfection is mandatory before reuse. Because "high-level chemical disinfectants rely on clean and dry surfaces," the probe must be thoroughly cleaned and dried before HLD — a wet surface dilutes the disinfectant and can compromise efficacy (AIUM Guidelines). Acceptable HLD agents include glutaraldehyde, hydrogen peroxide, OPA, and peracetic acid systems cleared by the FDA (FDA, Cleared Sterilants and High-Level Disinfectants).

3. Rinsing and Drying

• Rinse thoroughly with potable water following the disinfectant manufacturer's instructions to remove chemical residue before the probe contacts a patient again.
• Dry completely before storage.

4. Storage

• Store HLD-processed probes according to their disinfection level, in a manner that prevents recontamination (e.g., dedicated cabinets, not loose in a drawer with other equipment).

5. PPE and Hand Hygiene

• Remove gloves, dispose of them properly, and wash hands after completing reprocessing (AIUM Guidelines).

Preventing Probe Damage During Reprocessing

Ultrasound transducers are precision instruments, and incorrect reprocessing is a leading cause of probe failure. AIUM cites data showing that in a hospital setting, 88% of ultrasound system failures were attributable to the transducer rather than the console, and that probe performance was compromised in nearly 40% of transducers evaluated in one study, often due to reprocessing damage (AIUM Guidelines).

Common causes of reprocessing-related probe damage:

• Immersing beyond the rated line. Many probes may only be submerged up to a specific point on the cable near the connector; submerging the connector itself can cause irreversible damage.
• Resting the probe head on the container bottom. Some manufacturers warn that array crystals may be damaged if the transducer rests or impacts the bottom of a soaking container rather than being suspended.
• Using non-validated chemicals. "Using chemicals and reprocessing protocols or methods not validated by the responsible OEM may potentially damage a given transducer and present a patient safety issue or produce a non-diagnostic study" (AIUM Guidelines).
• Using non-validated automated reprocessors. Automated endoscope/probe reprocessing systems not validated by the transducer manufacturer have been linked to higher failure rates, particularly in endocavitary transducers.

Probe Damage Prevention Checklist

• Always follow the specific transducer OEM's IFU — not generic society guidelines alone
• Confirm immersion depth limits before soaking any probe
• Suspend the probe in disinfectant solution; never let it rest on the container bottom
• Use only disinfectants and reprocessing systems validated by the transducer manufacturer
• Inspect the acoustic lens, cable, housing, and connector at regular intervals for cracks, delamination, or discoloration
• Test image quality periodically with a tissue-mimicking phantom to detect element degradation not visible externally
• Retire or flag any probe with dead elements, reduced sensitivity, or physical damage — continued use can produce misleading diagnostic images

Leakage Testing: A Critical Safety Step Before HLD

Electrical and structural leakage testing is a mandatory safety and quality checkpoint for TEE probes in particular, given their invasive insertion into the esophagus adjacent to the heart. A documented outbreak of multidrug-resistant Pseudomonas aeruginosa was traced to a TEE probe with a small mechanical defect in its insertion tube that retained bacterial contamination despite centralized reprocessing — the sheath had not been used and the defect went undetected (AIUM Guidelines, citing Seki et al.).

Leakage testing checks two things simultaneously: whether the probe's outer sheath has been breached (allowing fluid ingress that can harbor pathogens and cause electrical failure) and whether current leakage exceeds safe limits for patient contact. Facilities accredited by the Intersocietal Accreditation Commission (IAC) are required to test the structural and electrical integrity of every TEE probe between each use with a dedicated ultrasound transducer leakage tester, documenting a pass/fail result and any action taken on a routine maintenance log (CS Medical, Electrical Leakage Testing). Leading manufacturers reinforce this in their own IFUs — GE states it is "strongly recommended that, before the probe is used again, [staff] conduct a current leakage test to ensure the electrical safety of the probe and the patient," and Philips issues similar guidance (CS Medical, Electrical Leakage Testing).

Leakage Testing Checklist (TEE and Endocavity Probes)

• Perform a leakage test before every high-level disinfection cycle, not just periodically
• Use a calibrated, dedicated ultrasound transducer leakage tester compatible with the specific probe model
• Compare measured leakage current against the manufacturer's acceptable limits — do not use generic thresholds
• Document Pass/Fail results, date, operator, and any corrective action in a probe maintenance log
• Remove any probe that fails leakage testing from service immediately; do not attempt HLD or clinical use until repaired and re-verified
• Retain leakage test records to support accreditation requirements (e.g., IAC) and any warranty or resale documentation

Practical Notes for Imported/Refurbished Ultrasound Systems

Buyers and biomedical engineers receiving used ultrasound systems should treat every incoming endocavity or TEE probe as unverified until independently leakage-tested and visually inspected, regardless of any reprocessing documentation provided by the seller. Cracked housings, delaminated lenses, or degraded cable jackets are common in probes that have seen years of clinical use, and these defects are not always visible without functional and leakage testing. Establishing a receiving inspection protocol for every probe — before it is placed back into clinical service — protects both patients and the facility's investment.